SILVER SPRING
Furoscix ReadyFlow cleared for edema in heart failure, CKD
- Sponsor
- MannKind Corporation $MNKD
- Drug
- Furoscix ReadyFlow · furosemide
- Indication
- Edema in adults with heart failure or chronic kidney disease
FDA approves MannKind's Furoscix ReadyFlow autoinjector for edema in adults with heart failure or chronic kidney disease.
What this means
Furoscix ReadyFlow is a pre-filled, single-use device that delivers the diuretic furosemide under the skin to help remove excess fluid. The FDA cleared this new delivery system for treating swelling in adults with heart failure or chronic kidney disease. This provides a simpler, needle-free option for patients who need this common medication outside of a clinic setting.
Drug Watch — recent news on Furoscix ReadyFlow
- Treating Worsening Congestion With Subcutaneous Furosemide - Pharmacy Times
- MannKind Stock Rises As ADA 2026 Data Strengthen Afrezza, FUROSCIX Story - timothysykes.com
- MNKD Jumps As MannKind Showcases Strong Afrezza, FUROSCIX Data - timothysykes.com
- Q3 2026 Preview: 4 FDA Decisions to Watch - HCP Live
- Continuous Infusion and Sequential Nephron Blockade Versus Bolus Furosemide in Acute Heart Failure: A Systematic Review - Cureus